Suliqua यूरोपीय संघ - डेनिश - EMA (European Medicines Agency)

suliqua

sanofi winthrop industrie - insulin glargine, lixisenatide - diabetes mellitus, type 2 - narkotika anvendt i diabetes - suliqua is indicated for the treatment of adults with insufficiently controlled type 2 diabetes mellitus to improve glycaemic control as an adjunct to diet and exercise in addition to metformin with or without sglt-2 inhibitors.

Clomicalm यूरोपीय संघ - डेनिश - EMA (European Medicines Agency)

clomicalm

virbac s.a. - clomipramine hydrochloride - psychoanaleptics - hunde - as an aid in the treatment of separation related disorders in dogs manifested by destruction and inappropriate elimination (defecation and urination) and only in combination with behavioural modification techniques.

Leflunomide Zentiva (previously Leflunomide Winthrop) यूरोपीय संघ - डेनिश - EMA (European Medicines Agency)

leflunomide zentiva (previously leflunomide winthrop)

zentiva k.s. - leflunomid - arthritis, rheumatoid; arthritis, psoriatic - immunosuppressiva - leflunomid er indiceret til behandling af voksne patienter med aktiv leddegigt, som en 'sygdomsmodificerende antireumatiske stof" (dmard);aktiv psoriasis artrit. senere eller samtidig behandling med hepatotoksiske eller haematotoxic dmard (e. methotrexat) kan resultere i en øget risiko for alvorlige bivirkninger; derfor skal indledningen af ​​leflunomidbehandling nøje overvejes med hensyn til disse fordele / risikofaktorer. desuden skifter fra leflunomid til en anden dmard uden at følge udvaskningen procedure kan også øge risikoen for alvorlige bivirkninger selv i lang tid efter skifte.

Ventavis यूरोपीय संघ - डेनिश - EMA (European Medicines Agency)

ventavis

bayer ag - iloprost - hypertension, lunge - antitrombotiske midler - behandling af patienter med primær lunghypertension, klassificeret som new york heart association funktionelle klasse iii, for at forbedre træningskapacitet og symptomer.

Teysuno यूरोपीय संघ - डेनिश - EMA (European Medicines Agency)

teysuno

nordic group b.v. - tegafur, gimeracil, oteracil - mave neoplasmer - antineoplastiske midler - teysuno is indicated in adults:- for the treatment of advanced gastric cancer when given in combination with cisplatin (see section 5. - as monotherapy or in combination with oxaliplatin or irinotecan, with or without bevacizumab, for the treatment of patients with metastatic colorectal cancer for whom it is not possible to continue treatment with another fluoropyrimidine due to hand-foot syndrome or cardiovascular toxicity that developed in the adjuvant or metastatic setting.

Dolenio 393 mg filmovertrukne tabletter डेनमार्क - डेनिश - Lægemiddelstyrelsen (Danish Medicines Agency)

dolenio 393 mg filmovertrukne tabletter

blue bio pharmaceuticals ltd. - glucosaminsulfat natriumchlorid - filmovertrukne tabletter - 393 mg

Imatinib "Cipla" 100 mg kapsler, hårde डेनमार्क - डेनिश - Lægemiddelstyrelsen (Danish Medicines Agency)

imatinib "cipla" 100 mg kapsler, hårde

cipla europe nv - imatinibmesilat - kapsler, hårde - 100 mg

Sativex 27+25 mg/ml mundhulespray, opløsning डेनमार्क - डेनिश - Lægemiddelstyrelsen (Danish Medicines Agency)

sativex 27+25 mg/ml mundhulespray, opløsning

jazz pharmaceuticals ireland ltd - cannabis ekstrakt (cbd), cannabis ekstrakt (thc) - mundhulespray, opløsning - 27+25 mg/ml

Nelstatine 10+10 mg tabletter डेनमार्क - डेनिश - Lægemiddelstyrelsen (Danish Medicines Agency)

nelstatine 10+10 mg tabletter

alchemia ltd. - ezetimib, simvastatin - tabletter - 10+10 mg

Sugammadex Mylan यूरोपीय संघ - डेनिश - EMA (European Medicines Agency)

sugammadex mylan

mylan ireland limited - sugammadex sodium - neuromuskulær blokade - alle andre terapeutiske produkter - reversal of neuromuscular blockade induced by   rocuronium or vecuronium in adults. for the paediatric population: sugammadex is only recommended for routine reversal of rocuronium induced blockade in children and adolescents aged 2 to 17 years.